BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2459081)

  • 1. [Prostate-specific antigen as a prognostic parameter of treated prostate carcinoma--a reliable tumor marker?].
    Knönagel H; Gautschi K; Vonderschmitt DJ; Hauri D
    Helv Chir Acta; 1988 Jul; 55(3):333-5. PubMed ID: 2459081
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of the immunohistochemical detection of PSA in the diagnosis of carcinoma of the prostate].
    Escaf S; Isorna S; Riesgo I
    Arch Esp Urol; 1987; 40(9):627-31. PubMed ID: 2449870
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The present role of prostatic specific antigen (PSA) as a tumor marker in carcinoma of the prostate.
    Parra RO
    Mo Med; 1991 Jun; 88(6):349-52. PubMed ID: 1712422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of prostatic specific antigen with Gleason grade in prostate cancer.
    Badalament RA; Drago JR
    In Vivo; 1989; 3(6):381-2. PubMed ID: 2485141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of prostate specific antigen. A review].
    Brasso K; Skaarup P; Roosen JU; Iverson P
    Ugeskr Laeger; 1998 Jul; 160(31):4510-6. PubMed ID: 9700305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prostate-specific antigen: its use in diagnosis and management of prostate cancer.
    Lange PH; Brawer MK
    Urology; 1989 Jun; 33(6 Suppl):13-7. PubMed ID: 2471346
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prostate-specific antigen (PSA): diagnostic and prognostic implications in the evaluation of carcinoma of the prostate].
    Lo Cigno M; Montanari F; Bercovich E; Soli M; Emili E; Dal Pozzo C; Platè L; Bianchi D
    Arch Ital Urol Nefrol Androl; 1989 Mar; 61(1):29-36. PubMed ID: 2469127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic intraepithelial neoplasia and prostate-specific antigen.
    Brawer MK
    Urology; 1989 Dec; 34(6 Suppl):62-5. PubMed ID: 2481364
    [No Abstract]   [Full Text] [Related]  

  • 11. [The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma].
    Wirth MP; Pilarsky C
    Urologe A; 1995 Jul; 34(4):297-302. PubMed ID: 7545844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostatic-specific antigen. A new tumor marker].
    Morote Robles J; Ruibal Morell A
    Med Clin (Barc); 1985 Dec; 85(19):801-4. PubMed ID: 2419714
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prostatic-specific antigen].
    Boccon-Gibod L
    Ann Urol (Paris); 1988; 22(3):159-60. PubMed ID: 2456711
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen in adenocarcinoma of the prostate.
    N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostate-specific antigen (PSA) is a valuable marker--if correctly used].
    Ekman P
    Lakartidningen; 1991 Jun; 88(24):2207-8. PubMed ID: 1711643
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endocrine differentiated prostate cancer. Histology and immunohistochemistry].
    Helpap B; Oehler U; Bollmann R
    Pathologe; 1990 Jan; 11(1):18-24. PubMed ID: 1690418
    [No Abstract]   [Full Text] [Related]  

  • 20. Papillary cystoadenocarcinoma of the prostate.
    Takeuchi S; Higashi Y; Kobayashi I; Takahama M
    Hinyokika Kiyo; 1992 Mar; 38(3):347-9. PubMed ID: 1381865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.